-
effectivehealthcare-admin.ahrq.gov/health-topics/personal-health-records
January 12, 2017 - Disorder
Technical Brief Archived May 21, 2015
Management Strategies to Reduce Psychiatric
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - some movement disorders (e.g., Parkinson’s
disease, dystonia), is being explored as a treatment for psychiatric … for movement disorders (e.g., Parkinson’s disease,
dystonia), is being explored as a treatment for psychiatric … humanitarian device exemption, which was the first FDA approval of any kind for a DBS device for
a psychiatric … Deep brain stimulation for non-
Parkinsonian neurologic and psychiatric
disorders. … receives FDA HDE approval to
commercialize the first deep brain stimulation
(DBS) therapy for a psychiatric
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - Compulsive
Disorder
Deep Brain Stimulation for MDD and OCD
Key facts: According to the American Psychiatric … Food and Drug
Administration (FDA) approval of any DBS device for a psychiatric indication. … for movement disorders (e.g., Parkinson’s disease, dystonia), is being
explored as a treatment for psychiatric … Clinical Pathway at Point of This Intervention
According to the American Psychiatric Association, guidelines … Deep brain stimulation for non-
parkinsonian neurologic and psychiatric
disorders.
-
effectivehealthcare-admin.ahrq.gov/products/pain-management-substance-abuse/research
April 01, 2021 - treat pain, concurrent use of other substances (e.g., alcohol, cannabis), and the presence of other psychiatric
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/nt_docs/topic-brief-updating-pharmacotherapy.pdf
September 30, 2022 - Issue:
The current 2018 American Psychiatric Association (APA) Practice Guideline for the
Pharmacological … American Psychiatric Association 2018 Practice
Guideline for the Pharmacological Treatment of Patients … Nalmefene in Alcohol Use Disorder Subjects
with Psychiatric Comorbidity: A Naturalistic Study. … American Psychiatric
Association. 2013. doi: https://doi.org/10.1176/appi.books.9780890425596
49. … Abbreviations: AHRQ =Agency for Healthcare Research and Quality; APA = American Psychiatric Association
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
January 01, 2022 - Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, Months Psychiatric … to 1.10)
Nervous system disorders: 9.5% (32/337) vs. 19.9% (67/337), RR 0.48 (95% CI 0.32 to 0.71)
Psychiatric
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
January 01, 2018 - Zealand, UK National Health Service, MyHealthApps, Health Living App
Guide - Vic Health, and American Psychiatric … Journal of
psychiatric research. 2018 Dec;107:73-8. doi: 10.1016/j.jpsychires.2018.10.006. … World psychiatry : official journal of the World Psychiatric Association (WPA). 2017
Oct;16(3):287-98
-
effectivehealthcare-admin.ahrq.gov/products/attention-deficit-hyperactivity-disorder/protocol
July 01, 2022 - In addition, screening and clinical evaluation of potential comorbid psychiatric conditions is a key … American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. … Arlington, VA: Psychiatric Publishing; 2013. Sciutto MJ, Eisenberg M. … American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. … Washington, DC: American Psychiatric Association; 1980. Rajabi S, Pakize A, Moradi N.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0365_10-28-2010.pdf
January 01, 2010 - Additionally, PTSD is complicated by its high rate of co-
morbidity with other psychiatric disorders,
-
effectivehealthcare-admin.ahrq.gov/health-topics/mental-disorders?page=1
May 24, 2016 - Disorder
Research Protocol Archived September 4, 2014
Management Strategies to Reduce Psychiatric
-
effectivehealthcare-admin.ahrq.gov/products/palliative-care-tools/technical-brief-2017
January 01, 2021 - Clinical Practice Guidelines for Palliative Care: structure and process, physical, psychological and psychiatric
-
effectivehealthcare-admin.ahrq.gov/products/depression-brain-injury/research
December 01, 2019 - Consideration of potential for coexisting psychiatric conditions is warranted.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - treat some movement disorders (e.g., Parkinson’s disease,
dystonia), is being explored for treating psychiatric … for movement disorders (e.g., Parkinson’s disease, dystonia), is being explored as a
treatment for psychiatric … that enrollment
remained open.
6
Clinical Pathway at Point of This Intervention
American Psychiatric … Deep brain stimulation for non-
Parkinsonian neurologic and psychiatric
disorders. … receives FDA HDE approval to
commercialize the first deep brain stimulation
(DBS) therapy for a psychiatric
-
effectivehealthcare-admin.ahrq.gov/products/depression-treatment-ssri/research-protocol
December 01, 2019 - depressive diagnoses, disease severity, ages, gender, racial and socioeconomic group, and medical or psychiatric … person (study investigator) with respect to study outcomes, seminal population characteristics (past psychiatric … composition, socio-economic status (income, education), sleeping disturbances or levels, co-morbidities (psychiatric … Measurable outcomes in psychiatric disorders: remission as a marker of wellness. … Measurable Outcomes in Psychiatric Disorders: Remission as a Marker of Wellness.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/suda-final-protocol.pdf
October 02, 2018 - sexually
transmitted infections2, unintended pregnancy3, criminal involvement4, school truancy5,
psychiatric … Tobacco is excluded.
2 Subpopulations considered: psychiatric co-morbidities, age (early, middle and … deemed to be at
least “problematic”
• Subpopulations of interest (not necessary for eligibility)
o Psychiatric … Methadone
• Buprenorphine
• Buprenorphine/Naloxone
• Naltrexone
o Medications to treat co-occurring psychiatric
-
effectivehealthcare-admin.ahrq.gov/products/trauma-informed-care/research
January 01, 2025 - insufficient to draw conclusions about the effects of Trauma Informed Care (TIC) in primary care or psychiatric
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - In addition, screening and clinical evaluation of potential
comorbid psychiatric conditions is a key … American Psychiatric Association. Diagnostic and Statistical Manual of Mental
Disorders. 5th ed. … Arlington, VA: Psychiatric Publishing; 2013.
28. Sciutto MJ, Eisenberg M. … American Psychiatric Association. Diagnostic and statistical manual of mental
disorders. 3rd ed. … Washington, DC: American Psychiatric Association; 1980.
79. Rajabi S, Pakize A, Moradi N.
-
effectivehealthcare-admin.ahrq.gov/products/cancer-end-of-life-measures-framework/research
January 01, 2019 - Domains include the structure and processes of care; physical, psychiatric, psychosocial, spiritual, … Specifically, we reorganized two of the domains into Psychiatric and Psychosocial to fit best with … which pain and dyspnea should be assessed
Screening
None
PEACE 9
Process
(Physical/Psychiatric … Assessment
Feasibility/usability: 38% of cancer patients met criteria, multiple hospitals
UHC 18
Psychiatric
-
effectivehealthcare-admin.ahrq.gov/products/cancer-quality-indicator-framework/research
January 01, 2019 - Domains include the structure and processes of care; physical, psychiatric, psychosocial, spiritual, … Specifically, we reorganized two of the domains into Psychiatric and Psychosocial to fit best with … which pain and dyspnea should be assessed
Screening
None
PEACE 9
Process
(Physical/Psychiatric … Assessment
Feasibility/usability: 38% of cancer patients met criteria, multiple hospitals
UHC 18
Psychiatric
-
effectivehealthcare-admin.ahrq.gov/products/mental-illness-outcomes/technical-brief
December 01, 2019 - facilitators of their implementation; and robust assessments of whether use of such measures improves medical, psychiatric